Biotech · Private company
Perceive Biotherapeutics, Inc.
Track this companyFree. Adds Perceive Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- VOY-101Phase 2 · Age-Related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- observational studyAge-Related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
- VOY-101Age-Related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Long-Term Follow Up of VOY-101 Non-nAMD Extension StudyENROLLING_BY_INVITATION · started Mar 3, 2026ClinicalTrials.gov NCT07660640 · fetched Nov 12, 2026
- Phase 1/2 Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 21, 2023ClinicalTrials.gov NCT06087458 · fetched Nov 12, 2026
- Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular DegenerationPHASE1_PHASE2 · UNKNOWN · started Nov 17, 2022ClinicalTrials.gov NCT05380492 · fetched Nov 12, 2026